Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma | MicrobiomeTrials← Back to trialsNCT07885319
Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-11-01Est. Completion: 2028-11-30
Enrollment target: 78 participants Locations- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
- Shanghai Chest Hospital, Shanghai, Shanghai Municipality, China
- West China Hospital of Sichuan University, Chengdu, Sichuan, China
Other microbiome trials you might be interested in
Unresectable Pleural Mesothelioma
This is a phase III, randomized, open-label, multicenter, global study to determine the efficacy and safety of Volrustom…
Santa Rosa, United StatesEst. completion Nov 16, 2028
MesotheliomaPleural MesotheliomaMalignant Pleural Mesothelioma
Patients with pleural mesothelioma (PM) that cannot be surgically removed will receive standard chemotherapy (cisplatin …
La Jolla, United StatesCompleted Jun 20, 2025